Skip to main content
OpenTrials

Clinical trial condition

Triple-negative Breast Cancer

Explore clinical trials studying Triple-negative Breast Cancer. Study availability and eligibility vary by location and protocol.

78 public trials 30 recruiting studies
Refine in advanced search Browse all conditions

Triple-negative Breast Cancer trial results

Completed

Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers

NCT03761914

Conditions
Acute Myelogenous Leukemia, Adnexal Diseases, Breast Diseases, +45 more
Locations
  • St. Joseph Heritage Healthcare Santa Rosa, California, United States
  • Innovative Clinical Research Institute (ICRI) Whittier, California, United States
  • Miami Cancer Institute at Baptist Health, Inc. Miami, Florida, United States
  • Memorial Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States
View Trial Details
Completed

Study of the Safety, Pharmacokinetics and Efficacy of Tinostamustine in Patients With Advanced Solid Tumors.

NCT03345485

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +50 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Stanford University Medical Center Palo Alto, California, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • New York University New York, United States
View all 13 locations
View Trial Details
Completed

Study of Imprime PGG and Pembrolizumab in Advanced Melanoma and Triple Negative Breast Cancer

NCT02981303

Conditions
Advanced Melanoma, Breast Diseases, Breast Neoplasms, +6 more
Locations
  • Arizona Center for Cancer Care Avondale, Arizona, United States
  • John Wayne Cancer Institute Santa Monica, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Sarah Cannon Research Institute Denver, Colorado, United States
View Trial Details
Completed

A Study of Ipatasertib in Combination With Atezolizumab and Paclitaxel as a Treatment for Participants With Locally Advanced or Metastatic Triple-Negative Breast Cancer

NCT04177108

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • USA Mitchell Cancer Institute Mobile, Alabama, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
  • UCLA Los Angeles, California, United States
  • Kaiser Permanente-SCPMG; Oncology Research San Diego, California, United States
View all 182 locations
View Trial Details
Completed

A Study of Atezolizumab and Paclitaxel Versus Placebo and Paclitaxel in Participants With Previously Untreated Locally Advanced or Metastatic Triple Negative Breast Cancer (TNBC)

NCT03125902

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • Stanford Cancer Center Stanford, California, United States
  • Florida Cancer Specialists; Department of Oncology Fort Myers, Florida, United States
  • Florida Cancer Specialist, North Region St. Petersburg, Florida, United States
  • Northwest Georgia Oncology Centers PC - Marietta Marietta, Georgia, United States
View all 161 locations
View Trial Details
Completed

A Study to Investigate Atezolizumab and Chemotherapy Compared With Placebo and Chemotherapy in the Neoadjuvant Setting in Participants With Early Stage Triple Negative Breast Cancer

NCT03197935

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • Stanford University Medical Center Palo Alto, California, United States
  • Norwalk Hospital Norwalk, Connecticut, United States
  • Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital Carrollton, Georgia, United States
  • Mercy Medical Center Baltimore, Maryland, United States
View all 68 locations
View Trial Details
Completed

TPST-1120 as Monotherapy and in Combination With Nivolumab in Subjects With Advanced Cancers

NCT03829436

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +58 more
Locations
  • University of California - San Francisco San Francisco, California, United States
  • Miami Cancer Institute Miami, Florida, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States
View Trial Details
Completed

A Study of KN046 in Subjects With Locally Advanced or Metastatic Triple-negative Breast Cancer

NCT03872791

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, Beijing Municipality, China
  • The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China
  • Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou, Guangdong, China
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
View Trial Details
Completed

A Study of the Safety, Efficacy, and Pharmacokinetics of Tiragolumab in Combination With Atezolizumab and Chemotherapy in Participants With Triple-Negative Breast Cancer

NCT04584112

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Univ of Chicago Chicago, Illinois, United States
  • Levine Cancer Institute Charlotte, North Carolina, United States
  • Magee-Woman's Hospital Pittsburgh, Pennsylvania, United States
View all 24 locations
View Trial Details

Related conditions